Showing results (1241-1250 of 5,930) with videos related to

Sort By:
Pageof 593
The Prostate|March 23, 2019
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysisMok Oh, Nasser Alkhushaym, Saad Fallatah, et al.
The Prostate|April 22, 2017
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abirateroneVincenza Conteduca, Orazio Caffo, Cristian Lolli, et al.
The Prostate|April 12, 2017
Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cellsDaisuke Nakata, Ryokichi Koyama, Kazuhide Nakayama, et al.
The Prostate|April 13, 2017
Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironmentBianca F Gonçalves, Silvana G P de Campos, Rejane M Góes, et al.
The Prostate|January 20, 2017
Amino Acid Profiling of Zinc Resistant Prostate Cancer Cell Lines: Associations With Cancer ProgressionMonika Kratochvilova, Martina Raudenska, Zbynek Heger, et al.
The Prostate|January 18, 2017
North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate CancerSami-Ramzi Leyh-Bannurah, Lars Budäus, Raisa Pompe, et al.
The Prostate|January 18, 2017
Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate CancerRahul R Parikh, John Byun, Sharad Goyal, et al.
The Prostate|January 18, 2017
Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate CancerMarian S Wettstein, Karim Saba, Martin H Umbehr, et al.
The Prostate|January 1, 2008
Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3Rebecka Hellsten, Martin Johansson, Anna Dahlman, et al.
The Prostate|January 1, 2008
Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell linesNadeem Shaida, Rosalind Launchbury, Jane L Boddy, et al.
Pageof 593